AJCN Tufts Nutrition Symposium, Boston Sept 24-26
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by von Castel-Roberts, K. M
Right arrow Articles by Bailey, L. B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by von Castel-Roberts, K. M
Right arrow Articles by Bailey, L. B
Agricola
Right arrow Articles by von Castel-Roberts, K. M
Right arrow Articles by Bailey, L. B
American Journal of Clinical Nutrition, Vol. 85, No. 4, 1057-1061, April 2007
© 2007 American Society for Nutrition

ORIGINAL RESEARCH COMMUNICATION

Holo-transcobalamin is an indicator of vitamin B-12 absorption in healthy adults with adequate vitamin B-12 status1,2,3

Kristina M von Castel-Roberts, Anne Louise Morkbak, Ebba Nexo, Claire A Edgemon, David R Maneval, Jonathan J Shuster, John F Valentine, Gail PA Kauwell and Lynn B Bailey

1 From the Departments of Food Science and Human Nutrition (KMvCR, CAE, DRM, GPAK, and LBB), Health Policy and Epidemiology (JJS), and Medicine (JFV), the General Clinical Research Center (JJS), University of Florida, Gainesville, and the Department of Clinical Biochemistry, Nørrebrogade, Aarhus Sygehus, Aarhus, Denmark (ALM and EN)

Background:It has been hypothesized that the response of holo-transcobalamin (holo-TC) to oral vitamin B-12 may be used to assess absorption. To develop a reliable clinical absorption test that uses holo-TC, it is necessary to determine the optimal timeline for vitamin B-12 administration and postdose assessment.

Objective:The objective of this study was to assess the magnitude and patterns of change in the postabsorption response of holo-TC to oral vitamin B-12.

Design:Adult (18–49 y) male and female participants (n = 21) with normal vitamin B-12 status were given three 9-µg doses of vitamin B-12 at 6-h intervals beginning early morning (baseline) on day 1. Blood was drawn at 17 timed intervals over the course of 3 d for the analysis of holo-TC and other indicators of vitamin B-12 status.

Results:Mean holo-TC increased significantly (P < 0.001) from baseline at 6 h (11%) and 24 h (50%). TC saturation increased significantly (P < 0.001) from baseline at 12.5 h (33%) and 24 h (50%). The mean cobalamin concentration changed significantly (P < 0.001) from baseline at 24 h (15%) and 48 h (14%). The ratio of holo-TC to cobalamin increased significantly (P < 0.001) at 24 h (32%).

Conclusions:The greatest increase in holo-TC was observed 24 h after ingestion of three 9-µg doses of vitamin B-12. Our results indicate that a vitamin B-12 absorption test based on measurement of holo-TC after administration of three 9-µg doses of vitamin B-12 should run for 24 h.

Key Words: Transcobalamin • holo-transcobalamin • holo-TC • vitamin B-12 • vitamin B-12 absorption • healthy adults






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by The American Society for Nutrition